

Heat treatment firm Bodycote posted an 8.7% rise in half year pre-tax profit and said its expects growth in aerospace, energy and new technologies to ...


ARM: Citigroup cuts target from 730p to 600p, buy recommendation maintained. AstraZeneca: Bernstein reduces target from 3,037p to 3,002p, market perf...


Aegis: Exane BNP Paribas downgrades to neutral, target upped from 220p to 240p; UBS downgrades to neutral, target upped from 195p to 240p; HSBC downgr...


Stephen Harris, who has held the role of Chief Executive Officer at FTSE 250 heat treatment firm Bodycote for over three years, sliced off a sizeable ...


The heat treatment firm Bodycote says it will open a new surface technology plant in Houston, Texas. The new plant, scheduled to open during the thir...


Bodycote, the heat treatment firm, has made a sensible purchase of US outfit Curtiss-Wright, thinks Tempus in the Times. Revenues have also been str...


ARM Holdings: Investec maintains buy rating and 800p target; Natixis upgrades from neutral to buy, target lifted from 600p to 625p; JP Morgan Cazenove...


- Q1 GDP expected to be flat - ARM up on upgrades, Apple earnings - Ex-div stocks lead the downside Stocks rose moderately in early trade on Wednesda...